FR2652742A1 - Anallergic cosmetic and dermopharmaceutical compositions - Google Patents
Anallergic cosmetic and dermopharmaceutical compositions Download PDFInfo
- Publication number
- FR2652742A1 FR2652742A1 FR8913511A FR8913511A FR2652742A1 FR 2652742 A1 FR2652742 A1 FR 2652742A1 FR 8913511 A FR8913511 A FR 8913511A FR 8913511 A FR8913511 A FR 8913511A FR 2652742 A1 FR2652742 A1 FR 2652742A1
- Authority
- FR
- France
- Prior art keywords
- cosmetic
- compositions
- fucose
- anallergic
- compositions according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 239000002537 cosmetic Substances 0.000 title claims description 13
- 206010020751 Hypersensitivity Diseases 0.000 claims abstract description 12
- 208000026935 allergic disease Diseases 0.000 claims abstract description 10
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 9
- 102000008072 Lymphokines Human genes 0.000 claims abstract description 7
- 108010074338 Lymphokines Proteins 0.000 claims abstract description 7
- 230000007815 allergy Effects 0.000 claims abstract description 7
- 210000000987 immune system Anatomy 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 claims abstract description 3
- 230000009610 hypersensitivity Effects 0.000 claims abstract description 3
- 230000003472 neutralizing effect Effects 0.000 claims abstract description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 8
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 6
- 150000002772 monosaccharides Chemical class 0.000 claims description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- 229930182830 galactose Natural products 0.000 claims description 4
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-WISUUJSJSA-N aldehydo-L-xylose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WISUUJSJSA-N 0.000 claims description 2
- 229930195726 aldehydo-L-xylose Natural products 0.000 claims description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 2
- 150000004676 glycans Polymers 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 230000002009 allergenic effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 241001440269 Cutina Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011252 protective cream Substances 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
La présente invention a pour objet des compositions cosmétiques et dermo-pharmaceutiques anallergiques. The present invention relates to anallergic cosmetic and dermo-pharmaceutical compositions.
Les compositions cosmétiques peuvent être définies comme des compositions destinées à traiter ou améliorer les propriétés élastiques de la peau, accélérer la régénération de ltépiderme, modifier les teintes ou l'aspect de la peau, ou capter ou neutraliser les sécrétions des glandes sudoripares. Cosmetic compositions can be defined as compositions intended to treat or improve the elastic properties of the skin, accelerate the regeneration of the epidermis, modify the hues or appearance of the skin, or capture or neutralize the secretions of the sweat glands.
Les compositions dermo-pharmaceutiques peuvent être définies comme étant des compositions destinées à réaliser le traitement d'un trouble cutané ou à améliorer les conditions d'une cicatrisation. The dermo-pharmaceutical compositions can be defined as being compositions intended to carry out the treatment of a skin disorder or to improve the conditions of scarring.
Lors de la préparation d'une composition cosmétique et dermo-pharmaceutique, il est tenu compte du toucher et de la stabilité de la composition, à laquelle on fait subir des tests d'inocuité (irritation, allergie) sur une population animale limitée. When preparing a cosmetic and dermo-pharmaceutical composition, account is taken of the feel and the stability of the composition, which is subjected to harmlessness tests (irritation, allergy) on a limited animal population.
Si ces tests d'allergie donnent des résultats négatifs chez ltanimal, aucune conclusion rigoureuse ne peut être sérieusement tirée quant au risque allergique dans une population humaine importante. En effet, aucune technique de formulation ne permet d'obtenir des préparations topiques non allergisantes dans une population humaine importante. If these allergy tests give negative results in animals, no rigorous conclusion can be seriously drawn as to the allergic risk in a large human population. Indeed, no formulation technique makes it possible to obtain topical non-allergenic preparations in a large human population.
Or, une utilisation répétée de compositions cosmétiques risque de développer et d'exprimer chez certains individus une réaction cutanée d'hypersensibilité ou d'allergie. However, repeated use of cosmetic compositions risks developing and expressing in certain individuals a skin reaction of hypersensitivity or allergy.
Une solution serait de donner aux compositions cosmétiques et dermo-pharmaceutiques un caractère anallergique. A cet effet, il conviendrait de bloquer l'effet des lymphokin-es sécrétées par les cellules immunitaires. A l'état physiologique, ces lymphokines conduisent à l'expression clinique de la réaction allergique par phénomènes de recrutement/amplification. Pour disposer d'une composition anallergique, il conviendrait de bloquer la production des lymphokines en jouant sur le système immunitaire. Une telle solution présente des dangers pour les utilisateurs, et est absolument inenvisageable dans le domaine de la cosmétique et de la dermo-pharmacie. One solution would be to give cosmetic and dermo-pharmaceutical compositions an anallergic character. To this end, the effect of lymphokines secreted by immune cells should be blocked. In the physiological state, these lymphokines lead to the clinical expression of the allergic reaction by recruitment / amplification phenomena. To have an anallergic composition, it would be necessary to block the production of lymphokines by playing on the immune system. Such a solution presents dangers for users, and is absolutely unthinkable in the field of cosmetics and dermo-pharmacy.
La présente invention vise à remédier à ces inconvénients en fournissant de nouvelles compositions cosmétiques et dermo-pharmaceutiques non allergisantes, et pour lesquelles l'absence d'allergie est obtenue sans avoir à agir sur le système immunitaire. The present invention aims to remedy these drawbacks by providing new non-allergenic cosmetic and dermo-pharmaceutical compositions, for which the absence of an allergy is obtained without having to act on the immune system.
A cet effet, les compositions cosmétiques ou dermo-pharmaceutiques qu'elle concerne contiennent au moins un saccharide susceptible de neutraliser les lymphokines produites par le système immunitaire, provoquant ainsi une non expression de la réaction d'hypersensibilité ou allergie de contact. Cette technique est particulièrement intéressante car n'agissant pas sur le système immunitaire, on laisse celui-ci sécréter les lymphokines, ces dernières étant neutralisées au niveau de la peau par le ou les saccharides contenus dans la formulation cosmétique. To this end, the cosmetic or dermo-pharmaceutical compositions which it relates contain at least one saccharide capable of neutralizing the lymphokines produced by the immune system, thus causing non-expression of the hypersensitivity reaction or contact allergy. This technique is particularly interesting because it does not act on the immune system, it is allowed to secrete the lymphokines, the latter being neutralized in the skin by the saccharide (s) contained in the cosmetic formulation.
Selon une première forme de réalisation, les compositions selon l'invention contiennent des monosaccharides choisis parmi les fucose, galactose, xylose, ribose et rhamnose. Avantageusement, ces monosaccharides sont choisis parmi les L - OC - fucose, galactose, L-xylose, D-ribose, et
L-rhamnose.According to a first embodiment, the compositions according to the invention contain monosaccharides chosen from fucose, galactose, xylose, ribose and rhamnose. Advantageously, these monosaccharides are chosen from L - OC - fucose, galactose, L-xylose, D-ribose, and
L-rhamnose.
I1 est également possible de mettre en oeuvre lesdits saccharides composés de ces sucres ou ces monosaccharides intégrés dans une structure polysaccharide. Conformément à une autre caractéristique de l'invention, la concentration en saccharide est inférieure à 10 % en poids et de préférence entre 2,5 et 5 %. It is also possible to use said saccharides composed of these sugars or these monosaccharides integrated into a polysaccharide structure. According to another characteristic of the invention, the concentration of saccharide is less than 10% by weight and preferably between 2.5 and 5%.
I1 est donné ci-après plusieurs exemples de réalisation de compositions selon l'invention. I1 is given below several embodiments of compositions according to the invention.
COMPOSITIONS COSMETIQUES
1 - Antiperspirant
- Réhydrol antiperspirant 14
- Acide stéarique 2
- Arlamol E émollient / solvant 2
- Silicone volatile 19
- L - < - fucose 3
- Alcool 60
2 - Base pour crème de maquillage d'yeux
- Acide stéarique 30
- Petrolatum 6
- Lanoline 5
- Propylène glycol 5 - Triéthanolamine 4 - L - < - fucose 5 - Eau 45 3 - Crème protectrice - Dimethicone et trimethoxysilicate 2 - Dimethicone 2 - Acide stéarique 6 - Alcool cétylique 1,5 - Huile minérale légère 2,2 - Triéthanolamine 1,5 - Glycérine 2 - L - - fucose 2,5 - Eau qsp 100
COMPOSITIONS DERMO-PHARMACEUTIQUES 1 - Pommade antibactérienne - Monostéarate de glycérine 12 - Alcool cétylstéarylique 3 - Huile de paraffine 5 - Sulfate de néomycine 0,5 - Triglycéride d'acide caprylique/ caprique 5 - L - (- - fucose 3,5 - Eau 71 2 - Pommade antimycosique % - Cutina MD 6 (Glycérides d'acides palmitique et stéarique) - Alcool cétylstéarylique 1 - Esters d'acide oléique 5 - Monoéthanolamine d'acide undécylénique 2 - L - α- fucose 5 - Carbopol 940 1 - Triéthanolamine 0,6
- Alcool éthylique 46
- Eau 33,4
Comme il ressort de ce qui précède, l'invention apporte une grande amélioration à la technique existante en fournissant des compositions cosmétiques et dermo-pharmaceutiques possédant des propriétés non allergisantes, ce caractère non allergisant étant obtenu par mise en oeuvre de produits totalement naturels.COSMETIC COMPOSITIONS
1 - Antiperspirant
- Antiperspirant rehydrol 14
- Stearic acid 2
- Arlamol E emollient / solvent 2
- Volatile silicone 19
- L - <- fucose 3
- Alcohol 60
2 - Base for eye makeup cream
- Stearic acid 30
- Petrolatum 6
- Lanolin 5
- Propylene glycol 5 - Triethanolamine 4 - L - <- fucose 5 - Water 45 3 - Protective cream - Dimethicone and trimethoxysilicate 2 - Dimethicone 2 - Stearic acid 6 - Cetyl alcohol 1.5 - Light mineral oil 2.2 - Triethanolamine 1, 5 - Glycerin 2 - L - - fucose 2,5 - Water qs 100
DERMO-PHARMACEUTICAL COMPOSITIONS 1 - Antibacterial ointment - Glycerin monostearate 12 - Cetylstearyl alcohol 3 - Paraffin oil 5 - Neomycin sulfate 0.5 - Caprylic / capric acid triglyceride 5 - L - (- - fucose 3.5 - Water 71 2 - Antimycotic ointment% - Cutina MD 6 (Glycerides of palmitic and stearic acids) - Cetylstearyl alcohol 1 - Oleic acid esters 5 - Monoethanolamine undecylenic acid 2 - L - α - fucose 5 - Carbopol 940 1 - Triethanolamine 0.6
- Ethyl alcohol 46
- Water 33.4
As is apparent from the above, the invention provides a great improvement to the existing technique by providing cosmetic and dermo-pharmaceutical compositions having non-allergenic properties, this non-allergenic nature being obtained by using completely natural products.
Comme il va de soi, l'invention ne se limite pas aux seules compositions décrites ci-dessus à titre d'exemples ; elle en embrasse au contraire toutes les variantes. It goes without saying that the invention is not limited to the compositions described above by way of examples only; on the contrary, it embraces all its variants.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8913511A FR2652742B1 (en) | 1989-10-11 | 1989-10-11 | COSMETIC AND DERMO-PHARMACEUTICAL ANALLERGIC COMPOSITIONS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8913511A FR2652742B1 (en) | 1989-10-11 | 1989-10-11 | COSMETIC AND DERMO-PHARMACEUTICAL ANALLERGIC COMPOSITIONS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2652742A1 true FR2652742A1 (en) | 1991-04-12 |
| FR2652742B1 FR2652742B1 (en) | 1993-10-29 |
Family
ID=9386446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8913511A Expired - Fee Related FR2652742B1 (en) | 1989-10-11 | 1989-10-11 | COSMETIC AND DERMO-PHARMACEUTICAL ANALLERGIC COMPOSITIONS. |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2652742B1 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2756735A1 (en) * | 1996-12-11 | 1998-06-12 | Thorel Jean Noel | Agent for treating or preventing contact allergy |
| WO1998034589A1 (en) * | 1997-02-07 | 1998-08-13 | Henkel Kommanditgesellschaft Auf Aktien | Skin care product |
| EP0937454A3 (en) * | 1998-02-13 | 2000-03-15 | Beiersdorf Aktiengesellschaft | Cosmetic or dermatological compositions containing polysaccharides for the protection of sensitive skin against irritations |
| FR2853539A1 (en) * | 2003-04-08 | 2004-10-15 | Ind E Com De Cosmeticos Natura | Cosmetic composition with anti-aging effect on the skin contains rhamnose and fucose compounds and excipients, protects hyaluronic acid against decomposition induced by free radicals |
| WO2005041983A1 (en) | 2003-10-31 | 2005-05-12 | Pierre Fabre Dermo-Cosmetique | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| FR2912055A1 (en) * | 2007-02-06 | 2008-08-08 | Idenov Lab | Cosmetic composition useful for soothing skin irritations comprises mono- and polysaccharides, glycerol, sorbitol, yeast extract, olive oil extract and a shea extract |
| WO2019129823A1 (en) * | 2017-12-29 | 2019-07-04 | L'oreal | Use of fucose derivatives as deodorants |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH368267A (en) * | 1957-07-22 | 1963-03-31 | Chem Fab Promonta Ges Mit Besc | Skin care products |
| DE1948990A1 (en) * | 1968-10-02 | 1970-05-27 | Kolmar Laboratories | Means for topical treatment of the skin |
| EP0074264A2 (en) * | 1981-09-08 | 1983-03-16 | Unilever Plc | Shampoo |
| EP0141732A2 (en) * | 1983-10-25 | 1985-05-15 | L'oreal | Cosmetic cleansing composition, particularly eye make-up remover |
| JPS62412A (en) * | 1985-06-25 | 1987-01-06 | Shiseido Co Ltd | Cosmetic |
| EP0221728A2 (en) * | 1985-10-22 | 1987-05-13 | Anthony N. Silvetti, Sr. | Monosaccharide containing wound healing preparation |
| FR2609397A1 (en) * | 1988-02-23 | 1988-07-15 | Serobiologiques Lab Sa | Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature |
| EP0287876A1 (en) * | 1987-04-08 | 1988-10-26 | Henkel Kommanditgesellschaft auf Aktien | Hair-regenerating compositions |
-
1989
- 1989-10-11 FR FR8913511A patent/FR2652742B1/en not_active Expired - Fee Related
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH368267A (en) * | 1957-07-22 | 1963-03-31 | Chem Fab Promonta Ges Mit Besc | Skin care products |
| DE1948990A1 (en) * | 1968-10-02 | 1970-05-27 | Kolmar Laboratories | Means for topical treatment of the skin |
| EP0074264A2 (en) * | 1981-09-08 | 1983-03-16 | Unilever Plc | Shampoo |
| EP0141732A2 (en) * | 1983-10-25 | 1985-05-15 | L'oreal | Cosmetic cleansing composition, particularly eye make-up remover |
| JPS62412A (en) * | 1985-06-25 | 1987-01-06 | Shiseido Co Ltd | Cosmetic |
| EP0221728A2 (en) * | 1985-10-22 | 1987-05-13 | Anthony N. Silvetti, Sr. | Monosaccharide containing wound healing preparation |
| EP0287876A1 (en) * | 1987-04-08 | 1988-10-26 | Henkel Kommanditgesellschaft auf Aktien | Hair-regenerating compositions |
| FR2609397A1 (en) * | 1988-02-23 | 1988-07-15 | Serobiologiques Lab Sa | Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature |
Non-Patent Citations (6)
| Title |
|---|
| CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, vol. 46, no. 6, novembre 1968, pages 859-864; G.E. THOMPSON et al.: "The influence of sugars upon hypersensitivity reactions" * |
| DIALOG INFORMATION SERVICES, INC., BASE DE DONNEES 155: MEDLINE 66-90, numéro d'accés: 05504537; M. CASTELAIN et al.: "Les competitions antigeniques et les phenomenes d'extinction antigenique en allergie de contact", & ANN. DERMATOL. VENEREOL. 1984, vol. 111, no. 11, 1984, pages 1029-37 * |
| PATENT ABSTRACTS OF JAPAN, vol. 11, no. 167 (C-425)[2614], 28 mai 1987; & JP-A-62 412 (SHISEIDO CO., LTD) 06-01-1987 * |
| THE JOURNAL OF IMMUNOLOGY, vol. 120, no. 2, février 1978, pages 542-549, The Williams & Wilkins Co., US; A. AMSDEN et al.: "Studies on cellular receptors for lymphokines" * |
| THE JOURNAL OF IMMUNOLOGY, vol. 122, no. 3, mars 1979, pages 838-841, The Williams & Wilkins Co., US; T. BABA et al.: "Suppression of cell-mediated immune reactions by monosaccharides" * |
| THE JOURNAL OF INVESTIGATIONS DERMATOLOGY, vol. 75, no. 3, septembre 1980, pages 284-287, The Williams & Wilkins Co., US; S. HASEGAWA et al.: "Suppression of allergic contact dermatitis by alpha-L-fucose" * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2756735A1 (en) * | 1996-12-11 | 1998-06-12 | Thorel Jean Noel | Agent for treating or preventing contact allergy |
| WO1998034589A1 (en) * | 1997-02-07 | 1998-08-13 | Henkel Kommanditgesellschaft Auf Aktien | Skin care product |
| EP0937454A3 (en) * | 1998-02-13 | 2000-03-15 | Beiersdorf Aktiengesellschaft | Cosmetic or dermatological compositions containing polysaccharides for the protection of sensitive skin against irritations |
| FR2853539A1 (en) * | 2003-04-08 | 2004-10-15 | Ind E Com De Cosmeticos Natura | Cosmetic composition with anti-aging effect on the skin contains rhamnose and fucose compounds and excipients, protects hyaluronic acid against decomposition induced by free radicals |
| WO2004091568A3 (en) * | 2003-04-08 | 2005-05-06 | Ind E Com De Cosmeticos Natura | Cosmetic composition of two polysaccharides based on fucose and rhamnose |
| WO2005041983A1 (en) | 2003-10-31 | 2005-05-12 | Pierre Fabre Dermo-Cosmetique | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| US7666847B2 (en) | 2003-10-31 | 2010-02-23 | Pierre Fabre Dermo-Cosmetique | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| EP2266580A1 (en) * | 2003-10-31 | 2010-12-29 | Pierre Fabre Dermo-Cosmétique | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| US9163049B2 (en) | 2003-10-31 | 2015-10-20 | Pierre Fabre Dermo-Cosmetique | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| FR2912055A1 (en) * | 2007-02-06 | 2008-08-08 | Idenov Lab | Cosmetic composition useful for soothing skin irritations comprises mono- and polysaccharides, glycerol, sorbitol, yeast extract, olive oil extract and a shea extract |
| WO2019129823A1 (en) * | 2017-12-29 | 2019-07-04 | L'oreal | Use of fucose derivatives as deodorants |
| FR3076216A1 (en) * | 2017-12-29 | 2019-07-05 | L'oreal | USE OF FUCOSE DERIVATIVES AS DEODORANT AGENTS |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2652742B1 (en) | 1993-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69714714T2 (en) | USE OF AN EXTRACT OF AT LEAST ONE LABIATE OF THE GENUS ROSMARINARUS CULTIVATED IN VITRO IN A COMPOSITION | |
| DE69600431T2 (en) | Combination of an antimicrobial compound (e.g. the lipoamino acid N, n-octanoyl-glycine) and a monoalkylglycerol ether and their use as an antimicrobial agent | |
| EP0754449B1 (en) | Skin whitening composition and/or anti-aging composition and uses thereof | |
| EP1357884B1 (en) | Composition for treating keratinous materials comprising a cationic poly(alkyl) vinyllactam polymer and a conditioning agent | |
| CA2111506C (en) | Alkylpolyglycosid-based keratin material conditionning compositions and their use for hair cleaning et conditonning | |
| EP0236218B1 (en) | Cosmetic compositions containing an extract of silybum marianum fruits | |
| DE3624819C2 (en) | ||
| EP0673643B1 (en) | Cosmetic composition containing an association of superoxide dismutase and porphyrine | |
| CA2088895A1 (en) | Cosmetic composition comprising at least an alkylpolyglycoside and/or polyglycerol surfactant and at least an urethane-polyether | |
| EP0681827A1 (en) | Use of bioflavonoids as keratineous phaners protection agent | |
| CN1195517A (en) | Hair treatment composition | |
| FR2652742A1 (en) | Anallergic cosmetic and dermopharmaceutical compositions | |
| EP0662315B1 (en) | Cosmetic shampoos containing alpha-hydroxyacids | |
| FR2828804A1 (en) | Cosmetic complex for use in hair shampoos, conditioners and skin care products, comprises malic acid, sweet almond extract and fruit pulp extracts | |
| JP2968437B2 (en) | Cosmetic and Pharmaceutical Fields, In particular, Use of Large Feng Oil to Regulate Skin Pigmentation in Topicals | |
| EP0711545B1 (en) | Aqueous mild surfactants containing preparations for cosmetic and cleaning use | |
| FR2765803A1 (en) | Topical cosmetic and pharmaceutical compositions | |
| FR2735982A1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT OF PLANTS OF THE GENUS FILICIUM | |
| FR2676645A1 (en) | Novel cosmetic compositions for protecting the skin against UV radiation | |
| US20050053564A1 (en) | Use a plant extract to enhance hair growth and hair restoration for damaged hair | |
| EP0307277B1 (en) | Product on a silanol basis for the care of the superficial lymphatic vessels | |
| EP1047373B1 (en) | Cosmetic compositions containing an anionic alkylpolyglycoside surfactant, a galactomannan gum and their uses | |
| DE10123989A1 (en) | Use of salts(s) of trivalent or tetravalent metal ion with oligo- or polysaccharide(s) in composition for reducing production of and/or for removing sebum | |
| FR2767684A1 (en) | MAKE-UP REMOVER COMPOSITION | |
| EP1800656B1 (en) | Use of an polyoxyalkylenesorbitan ester as a soothing agent for scalp |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |
Effective date: 20060630 |